Skip to main content
Premium Trial:

Request an Annual Quote

Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays

NEW YORK (GenomeWeb) – Abbott announced today that it has received CE marking for its Alinity m molecular diagnostics system and assays, which are now available in countries that recognize the designation.

The firm said that its molecular system will help clinicians who are struggling to keep up with demand for infectious disease testing.

The MDx platform offers a number of initial assays, including virology testing for human immunodeficiency virus type 1, hepatitis B virus, and hepatitis C virus; sexual health-related testing for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium, or a CT/NG/TV/MG panel; and high-risk human papillomavirus testing.

Abbott said that the molecular system and assays provide flexibility for laboratory staff and faster testing results for clinicians and patients, and that it may reduce the lab equipment footprint from between four and six instruments to one. As a result, the system decreases space requirements and hours spent learning and maintaining different instruments, the firm said.

The Alinity m is not available in the US for diagnostic use.

The molecular diagnostic platform is part of a series of next-generation systems and assays from Abbott that also includes clinical chemistry, immunoassay, and hematology testing, and blood and plasma screening.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.